Predictive of Biomarkers of Healing in Chronic Venous Ulceration of the Lower Limb (MOJITO)
Chronic venous ulceration of the lower limb poses a significant problem to patients and healthcare providers alike. 1% of the population of Western countries have either an open or healed chronic venous ulcer.
However, the pathophysiological abnormalities are not entirely clear in how raised venous pressure translates into the changes seen in the skin culminating in an open ulcer. The standard treatment of this condition in the United Kingdom is to undertaken compression bandaging of the lower limb.
In order to further their knowledge of venous ulceration, the investigators seek to determine the biological profile of venous ulcers over a maximum of twenty-eight weeks and by dividing the groups into healing and non-healing wounds, the investigators may be able to demonstrate a difference in the biological profile.
This work may provide insights into predicting who will respond to treatment and targets for treatment in the future.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Clinical Study to Identify Biological Markers to Predict Wound Healing in Patients With Chronic Venous Ulceration of the Lower Limb|
- Biological profile of healing venous ulcers versus non-healing venous ulcers [ Time Frame: 20 weeks ] [ Designated as safety issue: No ]Repeated assays at weeks 0, 1, 2, 4, 8, 12 and 20. Markers of wound healing and metabonomic assays. Ulcers will be stratified into healing and non healing and differences in the biological profiles will be determined using multivariate statistical analysis.
- Differential biological response in non healing ulcers treated with a biological dressing. [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]Non healing ulcers at twenty weeks will be treated in addition to standard dressing with a biological augmented dressing approved for use in the UK. This will determine if an alternative biological profile can be obtained representing a 'healing' response.
Biospecimen Retention: Samples With DNA
Human serum Human urine Human venous ulcer fluid
|Study Start Date:||November 2013|
|Study Completion Date:||June 2015|
|Primary Completion Date:||June 2015 (Final data collection date for primary outcome measure)|
Chronic Venous Ulcer
Patients with a chronic venous ulcer defined as a wound of greater than four weeks in duration between the foot and the ankle with an Ankle Brachial Pressure Index greater than 0.85 and a colour venous duplex evidence of chronic venous insufficiency showing either reflux or obstruction.
Forty patients with chronic venous ulceration of the lower limb who meet the inclusion criteria will be entered into the study and assessed over a twenty week period with assessments at week 0, 1, 2, 4, 8, 12 and 20. Urine, serum and ulcer fluid will be sampled.
If the ulcer has not healed, further assessments using an approved biological dressing will be undertaken at weeks 20, 21, 22, 23, 25 and 28 with further sampling of ulcer fluid, urine and serum.
Samples will undergo metabolic profiling using established metabonomic techniques developed at Imperial College.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01998932
|Cambridge University Hospitals NHS Foundation Trust|
|Cambridge, United Kingdom|
|Imperial College Healthcare NHS Trust - Charing Cross Hospital|
|London, United Kingdom, W6 8RF|
|Principal Investigator:||Alun H Davies||Imperial College London|